RT Journal Article
SR Electronic
A1 Summers, Jaye
T1 Budesonide Shows Validated Promise in Patients With Eosinophilic Esophagitis
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 14
SP 16
OP 16
DO 10.1177/1559897715593915
UL http://mdc.sagepub.com/content/15/14/16.abstract
AB In a randomized placebo-controlled trial, adults and adolescents with active EoE both histologically and symptomatically were given either oral budesonide or placebo for 12 weeks. Using a validated symptom tool and biopsy data, the results suggest a significant improvement in both symptoms and histology among those in the budesonide group, with no impending safety signals.